Lorca, R.; Junco-Vicente, A.; Martin-Fernandez, M.; Pascual, I.; Aparicio, A.; Barja, N.; Cuesta-LLavona, E.; Roces, L.; Avanzas, P.; Moris, C.;
et al. Clinical Implications and Gender Differences of KCNQ1 p.Gly168Arg Pathogenic Variant in Long QT Syndrome. J. Clin. Med. 2020, 9, 3846.
https://doi.org/10.3390/jcm9123846
AMA Style
Lorca R, Junco-Vicente A, Martin-Fernandez M, Pascual I, Aparicio A, Barja N, Cuesta-LLavona E, Roces L, Avanzas P, Moris C,
et al. Clinical Implications and Gender Differences of KCNQ1 p.Gly168Arg Pathogenic Variant in Long QT Syndrome. Journal of Clinical Medicine. 2020; 9(12):3846.
https://doi.org/10.3390/jcm9123846
Chicago/Turabian Style
Lorca, Rebeca, Alejandro Junco-Vicente, Maria Martin-Fernandez, Isaac Pascual, Andrea Aparicio, Noemi Barja, Elias Cuesta-LLavona, Luis Roces, Pablo Avanzas, Cesar Moris,
and et al. 2020. "Clinical Implications and Gender Differences of KCNQ1 p.Gly168Arg Pathogenic Variant in Long QT Syndrome" Journal of Clinical Medicine 9, no. 12: 3846.
https://doi.org/10.3390/jcm9123846
APA Style
Lorca, R., Junco-Vicente, A., Martin-Fernandez, M., Pascual, I., Aparicio, A., Barja, N., Cuesta-LLavona, E., Roces, L., Avanzas, P., Moris, C., Coto, E., Rodríguez Reguero, J. J., & Gómez, J.
(2020). Clinical Implications and Gender Differences of KCNQ1 p.Gly168Arg Pathogenic Variant in Long QT Syndrome. Journal of Clinical Medicine, 9(12), 3846.
https://doi.org/10.3390/jcm9123846
